Literature DB >> 4328416

Mechanism of oncogenic transformation by Rous sarcoma virus. II. Effect of rifampin on Rous sarcoma virus infection.

N J Richert, P Balduzzi.   

Abstract

Rifampin partially inhibits focus formation and virus production in chick embryo fibroblasts infected with Bryan high-titer Rous sarcoma (RAV-1) virus. This inhibition occurs with exposure to rifampin during a critical period between day 1 and day 2 after infection. This suggests that the drug does not affect formation of the provirus or its transcription or translation after the "fixation" step, but it seems to affect one or more events which take place before fixation and activation of virus production.

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4328416      PMCID： PMC356214     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  12 in total

1.  Inhibitors of the RNA and DNA dependent polymerase activities of RNA tumour viruses.

Authors:  C Gurgo; R K Ray; L Thiry; M Green
Journal:  Nat New Biol       Date:  1971-01-27

2.  Inhibition of growth of uninfected and rous sarcoma virus-infected chick-embryo fibroblasts by rifampicin.

Authors:  H L Robinson; W S Robinson
Journal:  J Natl Cancer Inst       Date:  1971-04       Impact factor: 13.506

3.  Light inactivation of focus formation by chicken embryo fibroblasts infected with avian sarcoma virus in the presence of 5-bromodeoxyuridine.

Authors:  D Boettiger; H M Temin
Journal:  Nature       Date:  1970-11-14       Impact factor: 49.962

4.  Rifampicin inhibits focus formation in chick fibroblasts infected with Rous sarcoma virus.

Authors:  H Diggelmann; C Weissmann
Journal:  Nature       Date:  1969-12-27       Impact factor: 49.962

5.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

6.  Carcinogenesis by avian sarcoma viruses.

Authors:  H M Temin
Journal:  Cancer Res       Date:  1968-09       Impact factor: 12.701

Review 7.  Lysogeny: the integration problem.

Authors:  E R Signer
Journal:  Annu Rev Microbiol       Date:  1968       Impact factor: 15.500

8.  Rifampicin sensitivity of the components of DNA-dependent RNA polymerase.

Authors:  E di Mauro; L Synder; P Marino; A Lamberti; A Coppo; G P Tocchini-Valentini
Journal:  Nature       Date:  1969-05-10       Impact factor: 49.962

9.  Rifampicin inhibits the growth of some mammalian viruses.

Authors:  J H Subak-Sharpe; M C Timbury; J F Williams
Journal:  Nature       Date:  1969-04-26       Impact factor: 49.962

10.  Mechanism of oncogenic transformation by Rous sarcoma virus. I. Intracellular inactivation of cell-transforming ability of Rous sarcoma virus by 5-bromodeoxyuridine and light.

Authors:  P Balduzzi; H R Morgan
Journal:  J Virol       Date:  1970-04       Impact factor: 5.103
View more
  3 in total

1.  Induction of cytotoxic action by rifamycin in a system of normal allogeneic lymphocytes-target cells in vitro.

Authors:  A S Berman
Journal:  Bull Exp Biol Med       Date:  1974-10       Impact factor: 0.804

2.  Effects of polyadenylic acids on functions of murine RNA tumor viruses.

Authors:  R W Tennant; J G Farrelly; J N Ihle; B C Pal; F T Kenney; A Brown
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

Review 3.  Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery.

Authors:  Leena Abdulaziz; Esraa Elhadi; Ejlal A Abdallah; Fadlalbaseer A Alnoor; Bashir A Yousef
Journal:  J Exp Pharmacol       Date:  2022-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.